| Vincent L Hansen, MD | |
|
4403 Harrison Blvd, #1685, Ogden, UT 84403-3271 | |
| (801) 387-7150 | |
| (801) 387-7155 |
| Full Name | Vincent L Hansen |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 4403 Harrison Blvd, Ogden, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528044385 | NPI | - | NPPES |
| 04781 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 1556821205 (Utah) | Primary |
| Entity Name | Utah Hematology Oncology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427273705 PECOS PAC ID: 0941296453 Enrollment ID: O20040421001014 |
News Archive
Patients with hepatocellular carcinoma (HCC) waiting for a liver transplant in the USA are now significantly less likely to receive a new liver than they were around a decade ago. A nationwide study presented today at The International Liver Congress™ 2018 in Paris, France, has confirmed that patients with HCC on the liver transplant list in the USA were more than 50% less likely to receive a transplant in 2014-2016 than they were in 2005-2007.
Inspire Pharmaceuticals, announced today a strategic corporate restructuring designed to result in the Company focusing activities on its eye care business, allowing it to fully leverage existing commercial capabilities, pipeline assets and related corporate development and licensing opportunities.
Research in monkeys suggests the possibility that stress may increase risk for the most common type of uterine cancer, according to a report from Wake Forest University Baptist Medical Center.
The Innovation and Technology Commission of the Hong Kong government has awarded Pangu BioPharma, the Hong Kong subsidiary of aTyr Pharma, a second grant to fund research it is performing in collaboration with the Hong Kong University of Science and Technology (HKUST). The Innovation and Technology Fund (ITF) provides matching funds over the next 18 months to expand Pangu's successful work in the identification and characterization of naturally occurring splice variants of human tRNA synthetases.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Patients with hepatocellular carcinoma (HCC) waiting for a liver transplant in the USA are now significantly less likely to receive a new liver than they were around a decade ago. A nationwide study presented today at The International Liver Congress™ 2018 in Paris, France, has confirmed that patients with HCC on the liver transplant list in the USA were more than 50% less likely to receive a transplant in 2014-2016 than they were in 2005-2007.
Inspire Pharmaceuticals, announced today a strategic corporate restructuring designed to result in the Company focusing activities on its eye care business, allowing it to fully leverage existing commercial capabilities, pipeline assets and related corporate development and licensing opportunities.
Research in monkeys suggests the possibility that stress may increase risk for the most common type of uterine cancer, according to a report from Wake Forest University Baptist Medical Center.
The Innovation and Technology Commission of the Hong Kong government has awarded Pangu BioPharma, the Hong Kong subsidiary of aTyr Pharma, a second grant to fund research it is performing in collaboration with the Hong Kong University of Science and Technology (HKUST). The Innovation and Technology Fund (ITF) provides matching funds over the next 18 months to expand Pangu's successful work in the identification and characterization of naturally occurring splice variants of human tRNA synthetases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vincent L Hansen, MD 4403 Harrison Blvd, #1685, Ogden, UT 84403-3271 Ph: (801) 387-7150 | Vincent L Hansen, MD 4403 Harrison Blvd, #1685, Ogden, UT 84403-3271 Ph: (801) 387-7150 |
News Archive
Patients with hepatocellular carcinoma (HCC) waiting for a liver transplant in the USA are now significantly less likely to receive a new liver than they were around a decade ago. A nationwide study presented today at The International Liver Congress™ 2018 in Paris, France, has confirmed that patients with HCC on the liver transplant list in the USA were more than 50% less likely to receive a transplant in 2014-2016 than they were in 2005-2007.
Inspire Pharmaceuticals, announced today a strategic corporate restructuring designed to result in the Company focusing activities on its eye care business, allowing it to fully leverage existing commercial capabilities, pipeline assets and related corporate development and licensing opportunities.
Research in monkeys suggests the possibility that stress may increase risk for the most common type of uterine cancer, according to a report from Wake Forest University Baptist Medical Center.
The Innovation and Technology Commission of the Hong Kong government has awarded Pangu BioPharma, the Hong Kong subsidiary of aTyr Pharma, a second grant to fund research it is performing in collaboration with the Hong Kong University of Science and Technology (HKUST). The Innovation and Technology Fund (ITF) provides matching funds over the next 18 months to expand Pangu's successful work in the identification and characterization of naturally occurring splice variants of human tRNA synthetases.
› Verified 5 days ago
Ewa Gniado, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd Ste 3630, Ogden, UT 84403 Phone: 801-387-7900 Fax: 801-387-7910 | |
Jaclyn Nguyen, Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4403 Harrison Blvd Ste 3630, Ogden, UT 84403 Phone: 801-387-7900 | |
Dr. Timothy Trask, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-3654 | |
Gregory T Almony, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5405 S 500 E, Suite #204, Ogden, UT 84405 Phone: 801-479-0194 Fax: 801-479-5642 | |
Brian W Pugh, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 6028 S Ridgeline Dr, Ste 201, Ogden, UT 84405 Phone: 801-475-5400 Fax: 801-475-8614 | |
Dr. Jack D Wahlen, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4403 Harrison Blvd, Ste 3630, Ogden, UT 84403 Phone: 801-387-7900 Fax: 801-387-7910 | |
Gary K Goucher, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4403 Harrison Blvd, #3815, Ogden, UT 84403 Phone: 801-387-2575 Fax: 801-387-2585 |